Stock Scorecard



Stock Summary for Grifols SA (GRFS) - $8.47 as of 11/20/2024 4:08:17 PM EST

Total Score

10 out of 30

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for GRFS

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for GRFS

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for GRFS

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for GRFS

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for GRFS (38 out of 90)

Stock Price Rating (Max of 10) 4
Historical Stock Price Rating (Max of 10) 6
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 2
Analyst Buy Ratings (Max of 5) 2
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 5
Trading Volume (Max of 10) 6
Price to Earnings (Max of 10) 5

Latest News for for GRFS

Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8% 11/20/2024 2:30:00 PM
Aecom Reports Q4 Results, Joins Incyte And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - AECOM ( NYSE:ACM ) 11/19/2024 5:21:00 PM
Vaccinex Provides Update on ActivMAb® Platform: Multiple Project Deals and Presentation at SITC 11/7/2024 1:30:00 PM
Should ADMA Biologics Stock Be in Your Portfolio Pre-Q3 Earnings? 11/5/2024 7:02:00 PM
Infectious Disease Diagnostics Market to Reach USD 43.09 Billion by 2031 | SkyQuest Technology 10/24/2024 12:15:00 PM
ADMA Biologics Stock Skyrockets 262.1% YTD: How to Play the Stock? 10/15/2024 5:35:00 PM
Blood Screening Market Growth at USD 6.33 Billion by 2031 | SkyQuest Technology 10/9/2024 1:32:00 PM
Antibody Production Market Expected to Reach USD 30.7 Billion by 2031, Growing at a CAGR of 7.8% from 2023 to 2031: Transparency Market Research, Inc. 10/8/2024 11:35:00 AM
Plasma Fractionation Market to Surpass Market Valuation of USD 63.27 Billion by 2031 | SkyQuest Technology 9/30/2024 12:00:00 PM
Orange To Delist From NYSE To Reduce Financial Burdens - Orange ( NYSE:ORAN ) , Defiance Quantum ETF ( NASDAQ:QTUM ) 9/25/2024 1:34:00 PM

Financial Details for GRFS

Company Overview

Ticker GRFS
Company Name Grifols SA
Country USA
Description Grifols, SA is dedicated to obtaining, manufacturing, preparing and selling therapeutic products, mainly blood derivatives. The company is headquartered in Barcelona, Spain.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 6/30/2024
Next Earnings Date N/A

Stock Price History

Last Day Price 8.47
Price 4 Years Ago 18.05
Last Day Price Updated 11/20/2024 4:08:17 PM EST
Last Day Volume 631,700
Average Daily Volume 885,525
52-Week High 12.15
52-Week Low 5.30
Last Price to 52 Week Low 59.81%

Valuation Measures

Trailing PE 35.00
Industry PE 22.60
Sector PE 40.32
5-Year Average PE 23.86
Free Cash Flow Ratio 3.37
Industry Free Cash Flow Ratio 12.03
Sector Free Cash Flow Ratio 27.97
Current Ratio Most Recent Quarter 2.26
Total Cash Per Share 2.51
Book Value Per Share Most Recent Quarter 7.87
Price to Book Ratio 1.01
Industry Price to Book Ratio 5.31
Sector Price to Book Ratio 20.88
Price to Sales Ratio Twelve Trailing Months 0.97
Industry Price to Sales Ratio Twelve Trailing Months 11.82
Sector Price to Sales Ratio Twelve Trailing Months 7.11
Analyst Buy Ratings 1
Analyst Strong Buy Ratings 1

Share Statistics

Total Shares Outstanding 257,444,000
Market Capitalization 2,180,550,680
Institutional Ownership N/A

Dividends

Ex-Dividend Date 6/3/2021
Last Dividend Amount 0.20
Current Dividend Amount 0.46
Total Years Dividend Increasing 1
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 3
3-Year Average Dividend Yield 4.07%
5-Year Average Dividend Yield 2.29%
1-Year Dividend Growth Rate Percentage 126.66%
3-Year Dividend Growth Rate Percentage 7.17%
5-Year Dividend Growth Rate Percentage 5.04%
All-Time Dividend Growth Rate Percentage 16.22%
Dividend Payout Ratio 0.00%

Income Statement

Quarterly Earnings Growth YOY -66.70%
Annual Earnings Growth -71.52%
Reported EPS 12 Trailing Months 0.26
Reported EPS Past Year 0.39
Reported EPS Prior Year 0.46
Net Income Twelve Trailing Months 143,944,000
Net Income Past Year 59,315,000
Net Income Prior Year 208,279,000
Quarterly Revenue Growth YOY 12.20%
5-Year Revenue Growth 8.00%
Operating Margin Twelve Trailing Months 0.20

Balance Sheet

Total Cash Most Recent Quarter 644,942,000
Total Cash Past Year 529,577,000
Total Cash Prior Year 547,979,000
Net Cash Position Most Recent Quarter -6,293,508,000
Net Cash Position Past Year -7,685,720,000
Long Term Debt Past Year 8,215,297,000
Long Term Debt Prior Year 8,154,264,000
Total Debt Most Recent Quarter 6,938,450,000
Equity to Debt Ratio Past Year 0.41
Equity to Debt Ratio Most Recent Quarter 0.44
Total Stockholder Equity Past Year 5,827,166,000
Total Stockholder Equity Prior Year 6,129,938,000
Total Stockholder Equity Most Recent Quarter 5,349,895,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 234,763,000
Free Cash Flow Per Share Twelve Trailing Months 0.91
Free Cash Flow Past Year -87,137,000
Free Cash Flow Prior Year -386,427,000

Options

Put/Call Ratio 5.50
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.20
MACD Signal 0.16
20-Day Bollinger Lower Band 7.17
20-Day Bollinger Middle Band 8.57
20-Day Bollinger Upper Band 9.97
Beta 0.69
RSI 53.06
50-Day SMA 8.05
150-Day SMA 8.95
200-Day SMA 10.53

System

Modified 11/21/2024 2:19:28 AM EST